|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tominaga O, Nita ME, Nagawa H, Fujii S,
Tsuruo T and Muto T: Expressions of cell cycle regulators in human
colorectal cancer cell lines. Jpn J Cancer Res. 88:855–860. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rupnarain C, Dlamini Z, Naicker S and
Bhoola K: Colon cancer: Genomics and apoptotic events. Biol Chem.
385:449–464. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karin M: NF-kappaB and cancer: Mechanisms
and targets. Mol Carcinog. 45:355–361. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Whisenant J and Bergsland E:
Anti-angiogenic strategies in gastrointestinal malignancies. Curr
Treat Options Oncol. 6:411–421. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pancione M, Giordano G, Remo A, Febbraro
A, Sabatino L, Manfrin E, Ceccarelli M and Colantuoni V: Immune
escape mechanisms in colorectal cancer pathogenesis and liver
metastasis. J Immunol Res. 2014:6868792014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamauchi M, Lochhead P, Morikawa T,
Huttenhower C, Chan AT, Giovannucci E, Fuchs C and Ogino S:
Colorectal cancer: A tale of two sides or a continuum? Gut.
61:794–797. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deschoolmeester V, Baay M, Van Marck E,
Weyler J, Vermeulen P, Lardon F and Vermorken JB: Tumor
infiltrating lymphocytes: An intriguing player in the survival of
colorectal cancer patients. BMC Immunol. 11:192010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pagès F, Berger A, Camus M, Sanchez-Cabo
F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte
D, et al: Effector memory T cells, early metastasis and survival in
colorectal cancer. N Engl J Med. 353:2654–2666. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Titu LV, Monson JR and Greenman J: The
role of CD8(+) T cells in immune responses to colorectal cancer.
Cancer Immunol Immunother. 51:235–247. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chew A, Salama P, Robbshaw A, Klopcic B,
Zeps N, Platell C and Lawrance IC: SPARC, FOXP3, CD8 and CD45
correlation with disease recurrence and long-term disease-free
survival in colorectal cancer. PLoS One. 6:e220472011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shevach EM: Mechanisms of foxp3+ T
regulatory cell-mediated suppression. Immunity. 30:636–645. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xia M, Zhao MQ, Wu K, Lin XY, Liu Y and
Qin YJ: Investigations on the clinical significance of FOXP3
protein expression in cervical oesophageal cancer and the number of
FOXP3+ tumour-infiltrating lymphocytes. J Int Med Res.
41:1002–1008. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kobayashi N, Kubota K, Kato S, Watanabe S,
Shimamura T, Kirikoshi H, Saito S, Ueda M, Endo I, Inayama Y, et
al: FOXP3+ regulatory T cells and tumoral indoleamine
2,3-dioxygenase expression predicts the carcinogenesis of
intraductal papillary mucinous neoplasms of the pancreas.
Pancreatology. 10:631–640. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Matsuura K, Yamaguchi Y, Osaki A, Ohara M,
Okita R, Emi A, Murakami S and Arihiro K: FOXP3 expression of
micrometastasis-positive sentinel nodes in breast cancer patients.
Oncol Rep. 22:1181–1187. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kobayashi N, Hiraoka N, Yamagami W, Ojima
H, Kanai Y, Kosuge T, Nakajima A and Hirohashi S: FOXP3+ regulatory
T cells affect the development and progression of
hepatocarcinogenesis. Clin Cancer Res. 13:902–911. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Curiel TJ, Coukos G, Zou L, Alvarez X,
Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L,
Burow M, et al: Specific recruitment of regulatory T cells in
ovarian carcinoma fosters immune privilege and predicts reduced
survival. Nat Med. 10:942–949. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gemei M, Mirabelli P, Di Noto R, Corbo C,
Iaccarino A, Zamboli A, Troncone G, Galizia G, Lieto E, Del Vecchio
L and Salvatore F: CD66c is a novel marker for colorectal cancer
stem cell isolation and its silencing halts tumor growth in
vivo. Cancer. 119:729–738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Duxbury MS, Ito H, Zinner MJ, Ashley SW
and Whang EE: CEACAM6 gene silencing impairs anoikis resistance and
in vivo metastatic ability of pancreatic adenocarcinoma
cells. Oncogene. 23:465–473. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim KS, Kim JT, Lee SJ, Kang MA, Choe IS,
Kang YH, Kim SY, Yeom YI, Lee YH, Kim JH, et al: Overexpression and
clinical significance of carcinoembryonic antigen-related cell
adhesion molecule 6 in colorectal cancer. Clin Chim Acta.
415:12–19. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Blumenthal RD, Hansen HJ and Goldenberg
DM: Inhibition of adhesion, invasion and metastasis by antibodies
targeting CEACAM6 (NCA-90) and CEACAM5 (carcinoembryonic antigen).
Cancer Res. 65:8809–8817. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Duxbury MS, Ito H, Benoit E, Waseem T,
Ashley SW and Whang EE: A novel role for carcinoembryonic
antigen-related cell adhesion molecule 6 as a determinant of
gemcitabine chemoresistance in pancreatic adenocarcinoma cells.
Cancer Res. 64:3987–3993. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kobayashi M, Miki Y, Ebina M, Abe K, Mori
K, Narumi S, Suzuki T, Sato I, Maemondo M, Endo C, et al:
Carcinoembryonic antigen-related cell adhesion molecules as
surrogate markers for EGFR inhibitor sensitivity in human lung
adenocarcinoma. Br J Cancer. 107:1745–1753. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Litkouhi B, Litkouhi B, Fleming E, Welch
WR, Berkowitz RS, Birrer MJ and Mok SC: Overexpression of CEACAM6
in borderline and invasive mucinous ovarian neoplasms. Gynecol
Oncol. 109:234–239. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Oue N, Hamai Y, Mitani Y, Matsumura S,
Oshimo Y, Aung PP, Kuraoka K, Nakayama H and Yasui W: Gene
expression profile of gastric carcinoma: Identification of genes
and tags potentially involved in invasion, metastasis and
carcinogenesis by serial analysis of gene expression. Cancer Res.
64:2397–2405. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jantscheff P, Terracciano L, Lowy A,
Glatz-Krieger K, Grunert F, Micheel B, Brümmer J, Laffer U, Metzger
U, Herrmann R and Rochlitz C: Expression of CEACAM6 in resectable
colorectal cancer: A factor of independent prognostic significance.
J Clin Oncol. 21:3638–3646. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maraqa L, Cummings M, Peter MB, Shaaban
AM, Horgan K, Hanby AM and Speirs V: Carcinoembryonic antigen cell
adhesion molecule 6 predicts breast cancer recurrence following
adjuvant tamoxifen. Clin Cancer Res. 14:405–411. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual (7th). Springer.
New York, NY: 2010.
|
|
30
|
Ma Y, Ma L, Guo Q and Zhang S: Expression
of bone morphogenetic protein-2 and its receptors in epithelial
ovarian cancer and their influence on the prognosis of ovarian
cancer patients. J Exp Clin Cancer Res. 29:852010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Canna K, McArdle PA, McMillan DC, McNicol
AM, Smith GW, McKee RF and McArdle CS: The relationship between
tumour T-lymphocyte infiltration, the systemic inflammatory
response and survival in patients undergoing curative resection for
colorectal cancer. Br J Cancer. 92:651–654. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nosho K, Baba Y, Tanaka N, Shima K,
Hayashi M, Meyerhardt JA, Giovannucci E, Dranoff G, Fuchs CS and
Ogino S: Tumour-infiltrating T-cell subsets, molecular changes in
colorectal cancer and prognosis: Cohort study and literature
review. J Pathol. 222:350–366. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pagès F, Kirilovsky A, Mlecnik B, et al:
In situ cytotoxic and memory T cells predict outcome in patients
with early-stage colorectal cancer. J Clin Oncol. 27:5944–5951.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu W, Liu H, Song J, Fu HX, Qiu L, Zhang
BF, Li HZ, Bai J and Zheng JN: The appearance of Tregs in cancer
nest is a promising independent risk factor in colon cancer. J
Cancer Res Clin Oncol. 139:1845–1852. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhuo C, Li Z, Xu Y, et al: Higher
FOXP3-TSDR demethylation rates in adjacent normal tissues in
patients with colon cancer were associated with worse survival. Mol
Cancer. 13:1532014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Svensson H, Olofsson V, Lundin S, Yakkala
C, Björck S, Börjesson L, Gustavsson B and Quiding-Järbrink M:
Accumulation of CCR4+CTLA-4 FOXP3+CD25(hi)
regulatory T cells in colon adenocarcinomas correlate to reduced
activation of conventional T cells. PLoS One. 7:e306952012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Deschoolmeester V, Baay M, Lardon F,
Pauwels P and Peeters M: Immune cells in colorectal cancer:
Prognostic relevance and role of MSI. Cancer Microenviron.
4:377–392. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Viguier M, Lemaître F, Verola O, Cho MS,
Gorochov G, Dubertret L, Bachelez H, Kourilsky P and Ferradini L:
Foxp3 expressing CD4+CD25(high) regulatory T cells are
overrepresented in human metastatic melanoma lymph nodes and
inhibit the function of infiltrating T cells. J Immunol.
173:1444–1453. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Stefan Schölzel, Wolfgang Zimmermann,
Georg Schwarzkopf, Fritz Grunert, Brigitta Rogaczewski and John
Thompson: Carcinoembryonic antigen family members CEACAM6 and
CEACAM7 are differentially expressed in normal tissues and
oppositely deregulated in hyperplastic colorectal polyps and early
adenomas. Am J Pathol. 156:595–605. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Witzens-Harig M, Hose D, Jünger S,
Pfirschke C, Khandelwal N, Umansky L, Seckinger A, Conrad H,
Brackertz B, Rème T, et al: Tumor cells in multiple myeloma
patients inhibit myeloma-reactive T cells through carcinoembryonic
antigen-related cell adhesion molecule-6. Blood. 121:4493–4503.
2013. View Article : Google Scholar : PubMed/NCBI
|
